Genetic Testing Market Growth, Industry Outlook & Opportunities | DataM Intelligence
The Global Genetic Testing Market is expected to grow at a CAGR of 11.50% in the forecast period 2021-2028.
The Global Genetic Testing Market is expected to grow at a CAGR of 11.50% in the forecast period 2021-2028.”
CLEVELAND, OHIO, USA, January 25, 2022 /EINPresswire.com/ -- — DataM Intelligence
Market Overview
Genetic trying out is a clinical test that identifies adjustments in genes, chromosomes, or proteins. The effects of a genetic test can confirm or rule out a suspected genetic circumstance or assist determine someone's threat of growing or passing on a genetic ailment. Genetic trying out has substantially garnered demand because of the significance of early ailment analysis and genetic problems remedy.
Download free sample: https://www.datamintelligence.com/download-sample/genetic-testing-market
Market Dynamics
The increase of the global genetic trying out marketplace is pushed through the developing want for personalized remedy, the growing software of genetic assessments in oncology, and the rising awareness of prognosis and predictive screening.
The increasing focus by governments of various countries to regulate and create awareness regarding genetic tests will drive market growth.
Governments' increasing consciousness on regulating and creating attention regarding genetic exams has efficaciously resulted in the quicker adoption of these checks across the world. The increasing R&D funding and the sturdy market presence through great gamers within the market have created a sturdy entry barrier for brand spanking new entrants. Innovation in product layout, development in satisfactory, and sturdy distribution partnerships are key parameters to retain an aggressive area in the market. For example, in August 2020, Ricoh Company Ltd and DNA Chip Research Inc. Launched RICOH Standard DNA Series EGFR mutation Type001, a reference DNA plate for use within the blood-based genetic trying out in the prognosis of lung most cancers.
The adoption of direct-to-patron genetic checking out kits in countries just like the United States, China, and Japan, is multiplying. With increasing technological adoptions, attention packages, and a decline in costs, the DTC-GT (Direct-to-client genetic trying out) kits marketplace is possible to witness a vast raise over the forecast duration. Moreover, the untapped countries, like India and different developing international locations, are predicted to offer a beneficial opportunity for players seeking to set up their base in the genetic checking out marketplace.
Thus, a growing burden of continual diseases, technological advancements and inclination towards personalized medicine is predicted to result in a good-sized boom of the genetic testing marketplace over the forecast period.
Market Segmentation
By Type
Carrier Testing
Diagnostic Testing
New-born Screening
Predictive and Presymptomatic Testing
Prenatal Testing
Other
By Sample
Blood
Hair
Saliva
Others
By Technology
Biochemical Genetic Testing
Chromosomal Genetic Testing
Molecular Testing
Cytogenetic Testing
Others
By Disease
Alzheimer's Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington's Disease
Rare Diseases
Other
By Region
North America
Europe
Asia-Pacific
Middle East & Africa
South America
View full report: https://www.datamintelligence.com/research-report/genetic-testing-market
Competitive Landscape
The genetic testing market is highly competitive with local and global companies. Some of the key players contributing to the market's growth include Abbott Laboratories, BioRad Laboratories Inc., F Hoffmann-La Roche, Illumina Inc., Myriad Genetics Inc, Danaher Corporation Luminex Corporation, BioRad Laboratories Inc., PerkinElmer Inc, and Quest Diagnostics Incorporated, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which contribute to the growth of the Genetic Testing Market globally. For instance, in August 2020, the FDA approved Guardant360 CDx of Guardant Health and FoundationOne Liquid CDx of Foundation Medicine as a companion diagnostic test and general tumour profiling.
Trending Topics
Microbiology Culture Market, G-Protein Coupled Receptor (GPCR) Targeting Market, Immuno Oncology Assays Market
Sai Kiran
DataM Intelligence 4Market Research LLP
+1 877-441-4866
info@datamintelligence.com
Visit us on social media:
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.